Purchases and Sales Made in Q1 2023 in Biomarin Pharmaceutical Inc (BMRN)
This table provides information about the institutional ownership of Biomarin Pharmaceutical Inc (BMRN) during Q1 2023. The information is specifically focused on institutions that hold shares of BIOMARIN PHARMACEUTICAL INC.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 09, 2023
Q1 2023
|
Connor, Clark & Lunn Investment Management Ltd.
|
SELL
|
- |
-87.4K- 27.5% |
$7.67M - $10.3M
|
230K
$14.8M
|
|
|
May 11, 2023
Q1 2023
|
Bank Of Nova Scotia
|
SELL
|
- |
-88.9K- 41.15% |
$7.8M - $10.4M
|
127K
$8.17M
|
|
|
May 15, 2023
Q1 2023
|
Moore Capital Management, LP
New York, NY |
SELL
|
- |
-100K- 76.92% |
$8.77M - $11.7M
|
30K
$1.93M
|
|
|
May 15, 2023
Q1 2023
|
Hsbc Holdings PLC
London, X0 |
SELL
|
- |
-105K- 35.33% |
$9.19M - $12.3M
|
192K
$12.3M
|
|
|
May 15, 2023
Q1 2023
|
Ensign Peak Advisors, Inc
Salt Lake City, UT |
SELL
|
- |
-136K- 56.34% |
$12M - $16M
|
106K
$6.79M
|
|
|
May 15, 2023
Q1 2023
|
Pfm Health Sciences, LP
San Francisco, CA |
SELL
|
- |
-151K- 48.59% |
$13.2M - $17.7M
|
160K
$10.3M
|
|
|
May 15, 2023
Q1 2023
|
Ubs Asset Management Americas Inc
Chicago, IL |
SELL
|
- |
-157K- 15.44% |
$13.7M - $18.4M
|
857K
$55.1M
|
|
|
May 15, 2023
Q1 2023
|
Alyeska Investment Group, L.P.
Chicago, IL |
SELL
|
- |
-162K- 32.29% |
$14.2M - $19M
|
339K
$21.8M
|
|
|
May 15, 2023
Q1 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-207K- 18.89% |
$18.2M - $24.3M
|
888K
$57.1M
|
|
|
May 15, 2023
Q1 2023
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-278K- 19.73% |
$24.4M - $32.6M
|
1.13M
$72.7M
|
|
|
May 15, 2023
Q1 2023
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
SELL
|
- |
-292K- 12.22% |
$25.6M - $34.2M
|
2.1M
$135M
|
|
|
Apr 18, 2023
Q1 2023
|
Assenagon Asset Management S.A.
|
SELL
|
- |
-336K- 47.68% |
$29.5M - $39.4M
|
369K
$23.7M
|
|
|
May 04, 2023
Q1 2023
|
Barclays PLC
London, X0 |
SELL
|
- |
-378K- 19.05% |
$33.1M - $44.3M
|
1.6M
$103M
|
|
|
May 15, 2023
Q1 2023
|
Janus Henderson Group PLC
London, X0 |
SELL
|
- |
-451K- 11.6% |
$39.6M - $52.9M
|
3.44M
$221M
|
|
|
May 15, 2023
Q1 2023
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-456K- 58.03% |
$40M - $53.5M
|
330K
$21.2M
|
|
|
May 12, 2023
Q1 2023
|
Ubs Group Ag
|
SELL
|
- |
-472K- 70.7% |
$41.4M - $55.3M
|
196K
$12.6M
|
|
|
May 15, 2023
Q1 2023
|
Amundi
Paris, I0 |
SELL
|
- |
-506K- 30.25% |
$44.4M - $59.4M
|
1.17M
$75M
|
|
|
May 15, 2023
Q1 2023
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-585K- 97.5% |
$51.4M - $68.6M
|
15K
$965K
|
|
|
May 12, 2023
Q1 2023
|
Clearbridge Investments, LLC
New York, NY |
SELL
|
- |
-631K- 57.26% |
$55.4M - $74M
|
471K
$30.3M
|
|
|
May 15, 2023
Q1 2023
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
SELL
|
- |
-717KClosed |
$62.9M - $84M
|
0
$0
|
|
|
May 12, 2023
Q1 2023
|
1832 Asset Management L.P.
Toronto, A6 |
SELL
|
- |
-975K- 86.56% |
$85.5M - $114M
|
151K
$9.72M
|
|
|
May 15, 2023
Q1 2023
|
Viking Global Investors LP
|
SELL
|
- |
-3.11M- 58.88% |
$272M - $364M
|
2.17M
$139M
|
|
|
May 15, 2023
Q1 2023
|
Baker Bros. Advisors LP
New York, NY |
SELL
|
- |
-3.81M- 50.0% |
$334M - $447M
|
3.81M
$245M
|